Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saposnik, G.
Right arrow Articles by Hachinski, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saposnik, G.
Right arrow Articles by Hachinski, V.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction
Right arrow Prognosis
NEUROLOGY 2005;65:1169-1174
© 2005 American Academy of Neurology

Predictors of major neurologic improvement after thrombolysis in acute stroke

Gustavo Saposnik, MD, Silvia Di Legge, MD, Fiona Webster, MA and Vladimir Hachinski, MD

From the Stroke Program, Department of Clinical Neurological Sciences, London Health Science Center, The University of Western Ontario, London, Ontario, Canada.

Address correspondence and reprint requests to Dr. Gustavo Saposnik, 339 Windermere Rd., Stroke Service, Office 7-GE5, London Health Science Centre, London, ON N6A 5A5, Canada; e-mail: gsaposni{at}uwo.ca

Background: Major neurologic improvement at 24 hours after administration of recombinant tissue plasminogen activator (rt-PA) in acute stroke may predict good outcome at 3 months.

Objective: To identify predictors of major neurologic improvement at 24 hours after IV rt-PA administration and its relationship with outcome at 3 months.

Methods: The authors analyzed patients with acute stroke treated with IV rt-PA from two academic centers in London, Ontario, and 33 affiliated hospitals between 1999 and 2003. Major neurologic improvement was defined by a ≥8-point improvement in NIH Stroke Scale (NIHSS) score or an NIHSS score of 0 or 1 at 24 hours. Good outcome was defined as a 3-month modified Rankin Scale of 0 to 1.

Results: Of 219 patients with acute stroke treated with rt-PA, 61 (28%) had major neurologic improvement at 24 hours. Glucose levels <8 mmol/L (OR 4.98, 95% CI 1.6 to 15.2), lack of cortical involvement on 24 hour CT scan (OR 3.97, 95% CI 1.87 to 8.43), and female sex (OR 2.4, 95% CI 1.12 to 5.13) were associated with major neurologic improvement after adjusting for covariates. Patients with major neurologic improvement had a shorter hospital stay (6.7 vs 14.3 days; p = 0.001). Major neurologic improvement was an independent predictor of good outcome at 3 months (OR 12.8, 95% CI 4.72 to 34.6).

Conclusions: Major neurologic improvement after rt-PA was observed in 28% of patients and independently predicted good outcome at 3 months. Female sex, glucose levels < 8 mmol/L, and absence of cortical involvement at 24 hours CT scan were associated with major neurologic improvement.


Supported in part by a grant from the Canadian Institute for Health Research (CIHR) and the Heart Stroke Foundation of Canada (HSFC) given to Dr. Gustavo Saposnik obtained based on competitive applications following publication of grant advertisements.

Disclosure: The authors report no conflicts of interest.

Received March 8, 2005. Accepted in final form July 11, 2005.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
R.I. Aviv, J. Mandelcorn, S. Chakraborty, D. Gladstone, S. Malham, G. Tomlinson, A.J. Fox, and S. Symons
Alberta Stroke Program Early CT Scoring of CT Perfusion in Early Stroke Visualization and Assessment
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1975 - 1980.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. R. Yip and B. M. Demaerschalk
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Stroke, June 1, 2007; 38(6): 1952 - 1955.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M.S.V. Elkind, S. Prabhakaran, J. Pittman, W. Koroshetz, M. Jacoby, K. C. Johnston, and for the GAIN Americas Investigators
Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke
Neurology, March 13, 2007; 68(11): 842 - 848.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. M. Kent, H. P. Selker, R. Ruthazer, E. Bluhmki, and W. Hacke
Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke, December 1, 2006; 37(12): 2963 - 2969.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. D. Legge, G. Saposnik, Y. Nilanont, and V. Hachinski
Neglecting the Difference: Does Right or Left Matter in Stroke Outcome After Thrombolysis?
Stroke, August 1, 2006; 37(8): 2066 - 2069.
[Abstract] [Full Text] [PDF]


Home page
JWatch NeurologyHome page
Predictors of Good Outcome After rt-PA for Ischemic Stroke
Journal Watch Neurology, February 9, 2006; 2006(209): 7 - 7.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.